We are a UK-based startup founded in 2015 by scientists at the University of Oxford. The company was formed around the shared vision that targeted sampling of intestinal contents, in particular the gut microbiome, should be cost-effective and minimally invasive.

We are supported by seed funding from the Oxford Seed Fund at the Saïd Business School, University of Oxford, and grants from Innovate UK and the Higher Education Funding Council for England (HEFCE). The company holds an S/EIS advance assurance grant and full ownership over all IP rights.

We are currently looking for additional investment to help take our products to market.

We are a committed and diverse team with strong expertise in science and business.

Soren Krogsgaard Thomsen

Soren Krogsgaard Thomsen

Co-Founder, Managing Director

Soren is a medical scientist at the University of Oxford, with a background in the natural sciences and genetics research. He previously worked as a consultant for pharma and OBR consulting, and has published on his experiences as an academic entrepreneur. Soren’s current research is focused on translating large-scale genetic data into mechanisms for disease to inform new therapeutic strategies. He dreams of one day enabling similar population-wide microbiome studies using the platform technology under development at BioMe Oxford Ltd.

Dr Agnieszka Chomka

Dr Agnieszka Chomka

Co-Founder, Head of R&D

Agnieszka is an intestinal immunologist at the Kennedy Institute for Rheumatology, University of Oxford. Her main research interests focus on the microbial-host interactions in the large intestine. She was awarded the prestigious Wellcome Trust scholarship at the University of Oxford to conduct her research into the role of a tissue-resident regulatory immune cell population in the gut. Agnieszka has published her results in top peer-review research journals.

Dr Christian Grøndahl

Dr Christian Grøndahl

Non-executive Director

Christian has more than 20 years of experience in the pharmaceutical industry and the biotech sector. Throughout his career, he served as co-founder and
director of numerous biotech startups and also has strong expertise in the microbiome field through his role as co-founder and CEO of the microbiome technology startup SNIPR BIOME Ltd. He previously raised more than $100M of investment for early- stage biotech companies and also worked as CSO for of Zealand Pharma A/S for which he successfully saw through an IPO of €50M. In addition, he previously held research and corporate roles over a long career in Novo Nordisk A/S and served as partner of the investment trust Syncona Partner LLP.

Dr Patrick Albers

Dr Patrick Albers

Co-founder, Head of Technology

Patrick is an Evolutionary Biologist and former Marine Biologist. He completed his PhD in Genomic Medicine and Statistics at the University of Oxford. He previously studied at Harvard University for his MSc. He currently works as a postdoctoral researcher at the Big Data Institute at the University of Oxford. Patrick has experience as an entrepreneur and founded a design company in Germany, with company exit through acquisition in 2009.

Dr Matthias Thurner

Dr Matthias Thurner

Co-founder, Head of Marketing

Matthias Thurner is a computational biologist working at the University of Oxford with an interest in big data analysis and software development. He recently completed his DPhil degree in Genomic Medicine and Statistics. His research focused on the computational analysis of large-scale genetic and epigenetic datasets to understand complex disease biology. For BioMe Oxford Ltd, he applies his experience in statistical analysis to perform marketing analysis and develop models that aim to capture the market for microbiome-related disease applications.

Dr Natasha Ng

Dr Natasha Ng

Co-founder, Company Secretary

Natasha Ng is currently a research fellow at the Agency for Science, Technology and Research based in Singapore. Her research interests involve understanding the molecular mechanisms underlying type 2 diabetes and rare monogenic forms of diabetes. Her current as well as prior work at the University of Oxford has seen her successfully managing both small and large research collaborations. She hopes to contribute to efforts in both academic and biotech sectors that will soon translate into better disease diagnosis and management strategies.

Rasmus Poulsen

Rasmus Poulsen

Co-founder, Head of Finance

Rasmus Poulsen is an economist from the University of Copenhagen, with a focus on finance and strategic management. He previously worked within management consulting and healthcare economics. Rasmus is currently working in Novo Nordisk within R&D finance, where he supports the R&D organisation in financial decision making.